Literature DB >> 19812150

Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.

Manjula Kalia1, Vivek Chandra, Sheikh Abdul Rahman, Deepak Sehgal, Shahid Jameel.   

Abstract

The hepatitis E virus (HEV), a nonenveloped RNA virus, is the causative agent of hepatitis E. The mode by which HEV attaches to and enters into target cells for productive infection remains unidentified. Open reading frame 2 (ORF2) of HEV encodes its major capsid protein, pORF2, which is likely to have the determinants for virus attachment and entry. Using an approximately 56-kDa recombinant pORF2 that can self-assemble as virus-like particles, we demonstrated that cell surface heparan sulfate proteoglycans (HSPGs), specifically syndecans, play a crucial role in the binding of pORF2 to Huh-7 liver cells. Removal of cell surface heparan sulfate by enzymatic (heparinase) or chemical (sodium chlorate) treatment of cells or competition with heparin, heparan sulfate, and their oversulfated derivatives caused a marked reduction in pORF2 binding to the cells. Syndecan-1 is the most abundant proteoglycan present on these cells and, hence, plays a key role in pORF2 binding. Specificity is likely to be dictated by well-defined sulfation patterns on syndecans. We show that pORF2 binds syndecans predominantly via 6-O sulfation, indicating that binding is not entirely due to random electrostatic interactions. Using an in vitro infection system, we also showed a marked reduction in HEV infection of heparinase-treated cells. Our results indicate that, analogous to some enveloped viruses, a nonenveloped virus like HEV may have also evolved to use HSPGs as cellular attachment receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812150      PMCID: PMC2786843          DOI: 10.1128/JVI.00717-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns.

Authors:  C W Kim; O A Goldberger; R L Gallo; M Bernfield
Journal:  Mol Biol Cell       Date:  1994-07       Impact factor: 4.138

3.  Domain structure of heparan sulfates from bovine organs.

Authors:  M Maccarana; Y Sakura; A Tawada; K Yoshida; U Lindahl
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

4.  Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment.

Authors:  D S McClain; A O Fuller
Journal:  Virology       Date:  1994-02       Impact factor: 3.616

5.  Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors:  B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.

Authors:  Heidi Barth; Christiane Schafer; Mohammed I Adah; Fuming Zhang; Robert J Linhardt; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Toshihiko Toida; Toin H Van Kuppevelt; Erik Depla; Fritz Von Weizsacker; Hubert E Blum; Thomas F Baumert
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

7.  Purification and characterization of heparin lyases from Flavobacterium heparinum.

Authors:  D L Lohse; R J Linhardt
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

8.  Expression in animal cells and characterization of the hepatitis E virus structural proteins.

Authors:  S Jameel; M Zafrullah; M H Ozdener; S K Panda
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.

Authors:  Satoko Ashikari-Hada; Hiroko Habuchi; Yutaka Kariya; Nobuyuki Itoh; A Hari Reddi; Koji Kimata
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

View more
  76 in total

Review 1.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

2.  Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection.

Authors:  Atsushi Tanaka; Uranan Tumkosit; Shota Nakamura; Daisuke Motooka; Natsuko Kishishita; Thongkoon Priengprom; Areerat Sa-Ngasang; Taroh Kinoshita; Naokazu Takeda; Yusuke Maeda
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

3.  Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity.

Authors:  Dong Yang; Mei Jiang; Min Jin; Zhigang Qiu; Weihong Cui; Zhiqiang Shen; Bo Li; Lianfeng Gong; Zhaoli Chen; Xinwei Wang; Jun-Wen Li
Journal:  Virus Genes       Date:  2013-07-26       Impact factor: 2.332

4.  Crystal structure of the avian astrovirus capsid spike.

Authors:  Rebecca M DuBois; Pamela Freiden; Shauna Marvin; Muralidhar Reddivari; Richard J Heath; Stephen W White; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  Chicken Organic Anion-Transporting Polypeptide 1A2, a Novel Avian Hepatitis E Virus (HEV) ORF2-Interacting Protein, Is Involved in Avian HEV Infection.

Authors:  Huixia Li; Mengnan Fan; Baoyuan Liu; Pinpin Ji; Yiyang Chen; Beibei Zhang; Yani Sun; Baicheng Huang; Yuchen Nan; Zhenzhao Sun; James P Stewart; Julian A Hiscox; Qin Zhao; En-Min Zhou
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 6.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

Review 7.  Molecular functions of syndecan-1 in disease.

Authors:  Yvonne Hui-Fang Teng; Rafael S Aquino; Pyong Woo Park
Journal:  Matrix Biol       Date:  2011-10-18       Impact factor: 11.583

8.  An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.

Authors:  Seong Eun Jin; Jung-Eun Kim; Sun Yeou Kim; Bang Ju Park; Yoon-Jae Song
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

9.  Hepatitis e virus: current concepts and future perspectives.

Authors:  Harry R Dalton; Suzan D Pas; Richie G Madden; Annemiek A van der Eijk
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

10.  Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.

Authors:  Angela C Bradshaw; Alan L Parker; Margaret R Duffy; Lynda Coughlan; Nico van Rooijen; Veli-Matti Kähäri; Stuart A Nicklin; Andrew H Baker
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.